The Business Case for Vertical Integration in Medical Device Development

Written by Jon Smith, Vice President of Business Development, HiArc | Jul 7, 2026 1:55:27 PM

Vertical integration stops sounding like a buzzword pretty fast once a program starts slipping. A design tweak triggers a supplier delay. A tolerance issue forces a tooling revision. A test fails, and now three vendors are coordinating on root cause, each pulling in a different direction. The real question isn't whether integration is worth considering. It's whether we can afford to keep learning that lesson the slow way.

 

At its core, vertical integration is a strategic approach of bringing key capabilities such as design, prototyping, manufacturing, testing, and quality activities under one roof to help keep development and production more closely connected. This consolidation isn't about owning every capability, but about strategically controlling the functions that most directly influence the final product. 

 

Too often, programs suffer from delays, quality issues, cost overruns, and scaling challenges because critical activities are fragmented across multiple suppliers and organizations. Each handoff between vendors creates the potential for communication gaps, delayed feedback, conflicting priorities, and accountability challenges.  

 

But vertical integration is not a universal answer, and it's not cheap when pursued for the wrong reasons. The real value is about risk, specifically, the kind that hits speed to market, unit economics, reliability, and supply continuity. When we approach vertical integration with discipline, integration can cut delays, sharpen design-for-manufacturing decisions, and make scaling a lot smoother, especially for complex systems like diagnostics.

 

Fewer hand-offs, faster learning

 

Every handoff costs us something. Context fades. Assumptions slip through unchecked. Feedback arrives too late to be useful. In device development, those small losses stack up quickly because nothing in these systems is truly isolated — mechanics affect optics, fluidics drive assay performance, firmware shapes motion, and manufacturing decisions ripple straight into tolerances and real-world results.

 

Shrinking that distance changes how teams work. When design, prototyping, and manufacturing are closely connected, we iterate faster and learn sooner. A build issue doesn't sit in someone's queue for weeks. A tolerance question gets worked out with both design and process engineers in the same room, or at least the same conversation.

 

That speed isn't just about moving faster. It changes how we make decisions. When teams see downstream effects earlier, they make better tradeoffs. In device development, where late-stage changes are expensive and disruptive, getting that visibility early is genuinely worth a lot.

 

It's about total cost, not just unit cost

 

Integration often gets framed as a cost-cutting move. But the biggest savings rarely show up in a per-unit calculation. They come from avoiding rework, cutting rebuilds, and spending less time managing back-and-forth across organizations.

 

For complex diagnostics, delays are often more expensive than parts. A missed milestone can push out clinical work, delay revenue, and extend burn. Keeping key capabilities aligned under one plan is one of the most reliable ways to reduce that kind of exposure.

 

Integration isn't free, of course. It takes real investment in equipment, talent, and quality systems. That's why the practical move is strategic integration: bring in-house the capabilities that directly affect schedule, quality, and scale, and partner for the rest.

 

Clear accountability improves quality and reliability

 

When something breaks in production, figuring out why gets complicated fast, especially with multiple suppliers in the mix. Each team sees its own slice of the system and naturally focuses there.

 

Integration changes that. When one organization owns the path from design intent through manufacturing, accountability is clear. That matters for reliability, because many field issues don't come from component failures. They come from subtle system-level interactions: a connector under mechanical strain, a seal that behaves differently after repeated cleaning, a mount that shifts with temperature.

 

These aren't isolated problems. They're system-level challenges that require coordination across disciplines to solve. Integration makes that coordination possible, and meaningfully improves the odds that issues get caught early, fixed quickly, and don't come back.

 

When it makes sense and when it doesn't

 

Integration tends to make sense when products are complex, tolerances are tight, or subsystems interact in ways that are hard to validate separately. It's also valuable when demand is uncertain and we need flexibility, or when we're building a platform we expect to evolve over multiple generations.

 

It's especially worth considering when manufacturing is part of the product's competitive advantage. If performance depends on precise assembly, calibration, or testing, keeping those capabilities close to engineering helps protect quality as we scale.

 

It's not always the right move. If volumes are low and predictable, designs are stable, and we have a supplier base that's genuinely performing, building everything in-house can add overhead without adding value. The same is true for capabilities that don't directly shape what the product does.

 

A practical way to frame the decision: where could our program break? If the biggest risks involve supply continuity, build consistency, or the ability to learn and adjust quickly, integration likely pays for itself. If those risks are well-managed through partnerships, protect what's working.

 

A flexible path forward

 

Most teams want the upside of integration without carrying the full structural burden. An engineering-focused CDMO model can bridge that gap, not by owning everything, but by reducing friction, speeding up learning cycles, and supporting scaling through a coordinated approach that adjusts as forecasts change.